A Clinical trial to study the safety and efficacy of Loteprednol etabonate + Gatifloxacin in the treatment of post operative inflammation.
Phase 3
Completed
- Registration Number
- CTRI/2010/091/001085
- Lead Sponsor
- Allergan India Private Limited, Level 2, Prestige Obelisk, No.3, Kasturba Road, Bangalore - 560001
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Adult patients of both the sexes, 18 years and above.
Exclusion Criteria
Pregnant women and lactating mothers.
Presence of any other damage to eye/ nerve including physical damage.
Hypersensitivity or intolerance to fluoroquinolones or any other component of the medication.
Patients with serve/ uncontrolled renal, hepatic or endocrine abnormality.
Patients with concomitant fungus, virus or tuberculous infections of the eye.
Patients who have contracted more than 4 infections of the external eye with the duration of one of the infections being longer than 2 weeks during the 12 months prior to being considered for admission in to the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method